JPRN-UMIN000032193招募中未知
Efficacy and safety of combination therapy of corticosteroid and tacrolimus for patients with anti-melanoma differentiation antigen 5 antibody-positive dermatomyositis-associated interstitial lung disease: a prospective multicenter clinical trial - Combination therapy of corticosteroid and tacrolimus for anti-MDA5 antibody-positive DM-ILD
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine0 个研究点目标入组 40 人开始时间: 2018年4月13日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet the following criteria are excluded from this study: (1) Patients who require systemic high dose corticosteroid, immunosuppressants, intravenous immunoglobulin therapy, plasma exchange, or biologic agents for a disease other than DM/CADM-ILD at the registration (2) Patients with contraindication of prednisolone or tacrolimus (3) Patients with a serious comorbidity (e.g. advanced malignancy, imminent aortic aneurysm, and Liver cirrhosis) (4) Patients who are judged unqualified for this study by attending physician
研究者
相似试验
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
进行中（未招募）
不适用
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
已完成
不适用
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60
招募中
不适用
Efficacy and safety of combination therapy of tocilizumab and abatacept in patients with refractory systemic-onset juvenile idiopathic arthritisJPRN-UMIN000024178Yokohama City University Hospital Department of Pediatrics5
招募中
不适用
combination therapy of cognitive rehabilitation and emotion regulation based on dialectical behavior therapy in HIV patients with associated neurocognitive disorders.HIV.Human immunodeficiency virus [HIV] diseaseIRCT20211118053093N2Shiraz University of Medical Sciences70